Could a soy enzyme be the next heart helper?
NCT ID NCT06183307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether nattokinase, an enzyme from fermented soy, can reduce inflammation and improve cholesterol levels in people with high cholesterol. Researchers will measure blood markers of inflammation and heart risk in 48 adults over two months. The goal is to see if this supplement can help control heart disease risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Denise Mafra
RECRUITINGRio de Janeiro, Rio de Janeiro, 22260050, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better healthcare access save hearts after prison?
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple health chat slash heart disease and cancer risk?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- One scan, many answers: can a new CT predict heart risks after stenting?